Gal alpha(1-3) N-Glycan 2AB (500pmol/vial)>95.0%(HPLC)1vial

(+)-Fenchone>98.0%(GC)25mL

tert-Butyl (5-amino-6-methylpyridin-2-yl)carbamate, 97%, 250mg

N-(3-ETHOXYPHENYL)-4-PYRROLIDIN-1-YL-3-TRIFLUOROMETHYL-BENZAMIDE, 95.0%, 250mg

8-Chloro-6-(trifluoromethyl)imidazo[1,2-a]pyridine-2-carboxylic acid, 97.0%, 5g

(4-Methoxytetrahydro-2H-pyran-4-yl)methanol, 98%, 100mg

Tris(3-methoxyphenyl)phosphine>98.0%(HPLC)5g

(3,5-dimethylphenyl)acetic acid, 95.0%, 1g

3,7-Dimethyl-1-octanol>98.0%(GC)500mL

Ethyl 5-(trifluoromethyl)indole-2-carboxylate, 95.0%, 1g

N-Methoxydiacetamide [Selective Acetylating Reagent]>95.0%(GC)5g

(R)-4-(Iodomethyl)-2,2-dimethyl-1,3-dioxolane, 95.0%, 250mg

N-(2-methoxyethyl)-2-piperazin-1-ylacetamide, 1g